Up 15% Since Q2: Will the Uptrend in Docebo’s Stock Continue?

Given its healthy growth prospects and improving profitability, the uptrend in Docebo’s stock could continue.

| More on:
Illustration of data, cloud computing and microchips

Source: Getty Images

Last month, Docebo (TSX:DCBO) reported impressive second-quarter earnings and raised its 2024 guidance, improving investors’ confidence and leading to a healthy buying in the stock. The company’s stock price has increased by 15.4% since reporting its second-quarter earnings on August 8. However, DCBO still trades at around a 24% discount compared to its 52-week high. Amid this backdrop, let’s assess whether Docebo would be a buy at these levels by looking at its second-quarter earnings and growth prospects.

Docebo’s second-quarter earnings

For the second quarter, which ended on June 30, Docebo reported revenue of $53.05 million, representing a 22% increase from the previous year. The addition of 307 customers and the expansion of its average contract value by 9.7% drove its topline. It earned around 94% of its revenue from subscriptions.

Amid the topline growth, the cloud-based learning platform provider’s gross profits grew by 22% while its gross profit margin remained at 80.7%. Its net profits of $4.7 million during the quarter represent a substantial improvement from a loss of $5.7 million in the prior year’s quarter. However, removing one-time items, its adjusted net income stood at $7.9 million, representing 68% year-over-year growth. Further, the company closed the quarter with a recurring revenue of $205.9 million, a 19% increase from the previous year.

Docebo’s adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) increased by 158% to $8 million, while its adjusted EBITDA margin expanded from 7% to 15%. It also generated $6.8 million of cash from its operating activities. Meanwhile, its free cash flows stood at $8.4 million, representing 15.9% of its total revenue. Now, let’s look at its growth prospects.

Docebo’s growth prospects

Amid the growing adoption of digital learning solutions, rising speed of telecommunication services, and new product launches, the learning management solution (LMS) market is expanding. Meanwhile, Grand View Research projects the global LMS market to grow at an annualized rate of 19.5% from 2023 to 2030. The expanding addressable markets could benefit Docebo, which continues to invest in developing artificial intelligence-powered features to enhance customer experiences.

Further, the company has adopted several growth initiatives to expand its business in enterprise, OEMs (original equipment manufacturer), and government segments. Besides, its growing customer base and increasing average contract value could support its growth. Also, around 81% of its customers have chosen multi-year agreements, thus providing stability to its financials. Considering all these factors, I believe the company’s long-term growth prospects look healthy.

After reporting better-than-expected second-quarter performance, Docebo’s management raised its guidance for this year. The company’s management expects its topline to grow by 18-19%. Meanwhile, its adjusted EBITDA could come between 15-15.5%, an improvement from 9% in 2023.

Investors’ takeaway

Amid the recent buying, Docebo’s valuation has increased. It trades at 5.6 and 37.4 times analysts’ projected sales and earnings for the next four quarters. Although its valuation looks expensive, it is justified given its healthy growth prospects and improving profitability. So, investors with over three years of investment horizon can start accumulating the stock to earn superior returns. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends Docebo. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »